ARAY - Accuray Inc

NYSE * Health Care * Health Care Equipment & Supplies

$0.46

$-0.03 (-5.68%)

About Accuray Inc

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

ARAY Key Statistics

Market Cap

$49.88M

0

P/B Ratio

1.02

EPS

$-0.31

Revenue Growth

+0.2%

Profit Margin

-0.1%

Employees

990

How ARAY Compares to Peers

ARAY has the fastest revenue growth among competitors
ARAY is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

#2

of 2

Growth Rank

#1

of 2

Size Rank

#2

of 2

CompanyP/EGrowthCompare
ARAYN/A0%-
AMZN29.20%vs AMZN

Accuray Inc Company Information

Headquarters
California; U.S.A
Website
www.accuray.com
Sector
Health Care
Industry
Health Care Equipment & Supplies
Data Updated:
Ready to invest in ARAY?

Commission-free trading available. Affiliate links.

ARAY Lician Score

10% confidence
5.0/10
Neutral

ARAY has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ARAYacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ARAY Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

35810Value5.0Growth3.0Quality5.0Momentum5.0Safety5.04.6/10
5.0

Value

3.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for ARAY